First Volunteer Receives Lassa Fever Vaccine in Cutting-edge Oxford Trial
The first volunteer has received a dose in a first-in-human trial of a Lassa vaccine, marking a major milestone in the fight against the deadly virus. The trial, conducted by the Oxford Vaccine Group, and funded by the Coalition for Epidemic Preparedness Innovations (CEPI), will assess the safety and immune response of the ChAdOx1 Lassa […]
Read More




